(Q39422318)

11 September 2017

1 reference

title

Plasma level monitoring of antipsychotic drugs. Clinical utility (English)

1 reference

11 September 2017

Dahl SG

1

1 reference

11 September 2017

1 January 1986

1 reference

Clinical Pharmacokinetics

11 September 2017

1 reference

11 September 2017

11

1 reference

11 September 2017

36-61

1 reference

11 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198611010-00003

11 September 2017

0 references

cites work

Chlorpromazine levels and the outcome of treatment in schizophrenic patients.

1 reference

12 December 2020

Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients

1 reference

12 December 2020

Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays

1 reference

12 December 2020

Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study

1 reference

12 December 2020

The presence of 7-hydroxychlorpromazine in CSF of chloropromazine-treated patients

1 reference

12 December 2020

Therapeutic blood levels of fluphenazine: plasma or RBC determinations?

1 reference

12 December 2020

Clinical response and plasma haloperidol levels in schizophrenia

1 reference

12 December 2020

High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin

1 reference

12 December 2020

Measurement of Plasma and Erythrocyte Chlorpromazine and N-Monodesmethylchlorpromazine Levels by Gas Chromatography with a Nitrogen Sensitive Detector

1 reference

12 December 2020

Simultaneous determination of haloperidol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection

1 reference

12 December 2020

Blood Level Measurement of Psychoactive Drugs in Pediatric Psychiatry

1 reference

12 December 2020

Haloperidol plasma levels and clinical response: basic concepts and clinical data

1 reference

12 December 2020

Fluphenazine pharmacokinetics and therapeutic response

1 reference

12 December 2020

Neuroleptic blood levels and therapeutic effect

1 reference

12 December 2020

Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response

1 reference

12 December 2020

Analysis of chlorpromazine in plasma: Effect of specimen storage

1 reference

12 December 2020

Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays

1 reference

12 December 2020

Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study

1 reference

12 December 2020

Correlation between plasma concentration and clinical effect of neuroleptics and antidepressants

1 reference

12 December 2020

Effect of antiparkinsonian medication on plasma levels of chlorpromazine

1 reference

12 December 2020

Quantitative determination of haloperidol in human plasma by high-performance liquid chromatography

1 reference

12 December 2020

Thioridazine and the neuroleptic radioreceptor assay.

1 reference

12 December 2020

Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients

1 reference

12 December 2020

Fluphenazine plasma levels and clinical response

1 reference

12 December 2020

Plasma Level Monitoring of Antipsychotic Drugs

1 reference

12 December 2020

Within-Individual Variation in Steady State Plasma Levels of Different Neuroleptics and Prolactin

1 reference

12 December 2020

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

12 December 2020

Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms

1 reference

12 December 2020

Effect of lithium on plasma chlorpromazine levels

1 reference

12 December 2020

A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood

1 reference

12 December 2020

Does a plasma level of chlorpromazine help?

1 reference

12 December 2020

Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients

1 reference

12 December 2020

Neuroleptic Concentrations and Clinical Response

1 reference

12 December 2020

Dose-response relationships of perphenazine in the treatment of acute psychoses

1 reference

12 December 2020

Plasma levels of thiothixene by radioreceptor assay: clinical usefulness

1 reference

12 December 2020

Receptor techniques in the study of plasma levels of neuroleptics and antidepressant drugs

1 reference

12 December 2020

Thioridazine pharmacodynamics: clinical effects may depend upon drug metabolism.

1 reference

12 December 2020

Haloperidol plasma level monitoring in neuropsychiatric patients

1 reference

12 December 2020

Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia

1 reference

12 December 2020

Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis

1 reference

12 December 2020

Monitoring plasma concentrations of neuroleptics

1 reference

12 December 2020

Plasma level and effect of low-dose haloperidol in acute psychosis

1 reference

12 December 2020

Radioimmunoassay for the sulfoxide metabolite of trifluoperazine and its application to a kinetic study in humans

1 reference

12 December 2020

Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients

1 reference

12 December 2020

High Serum Neuroleptic Levels in Tardive Dyskinesia?

1 reference

12 December 2020

Plasma levels of haloperidol and clinical response

1 reference

12 December 2020

Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects

1 reference

12 December 2020

Relationship of serum haloperidol levels to clinical response in schizophrenic patients

1 reference

12 December 2020

Identification of O-demethylated and ring-hydroxylated metabolites of methotrimeprazine (levomepromazine) in man

1 reference

12 December 2020

Clinical use of the radioreceptor assay for neuroleptics

1 reference

12 December 2020

Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup

1 reference

12 December 2020

Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients

1 reference

12 December 2020

Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine

1 reference

12 December 2020

Prolactin releasing potencies of antipsychotic and related nonantipsychotic compounds in female rats: relation to clinical potencies

1 reference

12 December 2020

Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine

1 reference

12 December 2020

Acute extrapyramidal side effects: Serum levels of neuroleptics and anticholinergics

1 reference

12 December 2020

Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays

1 reference

12 December 2020

Plasma and erythrocyte levels of methotrimeprazine and two of its nonpolar metabolites in psychiatric patients.

1 reference

12 December 2020

Total and free plasma neuroleptic levels in schizophrenic patients

1 reference

12 December 2020

Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate

1 reference

12 December 2020

Measurement of haloperidol in human plasma using reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment

1 reference

12 December 2020

Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine

1 reference

12 December 2020

Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations

1 reference

12 December 2020

Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients

1 reference

12 December 2020

GLC Analysis of Loxapine, Amoxapine, and Their Metabolites in Serum and Urine

1 reference

12 December 2020

Reduced haloperidol: Effects on striatal dopamine metabolism and conversion to haloperidol in the rat

1 reference

12 December 2020

Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations

1 reference

12 December 2020

Serum neuroleptic concentrations and tardive dyskinesia

1 reference

12 December 2020

Problems in therapeutic blood monitoring of chlorpromazine.

1 reference

12 December 2020

The relationship between haloperidol blood levels and clinical responses

1 reference

12 December 2020

Pharmacokinetics of chlorpromazine after single and chronic dosage

1 reference

12 December 2020

Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients

1 reference

12 December 2020

Reduced steady-state plasma concentrations of chlorpromazine and indomethacin in patients receiving cimetidine

1 reference

12 December 2020

High-performance liquid chromatography of haloperidol in serum at the concentrations achieved during chronic therapy

1 reference

12 December 2020

Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia

1 reference

12 December 2020

Plasma haloperidol levels and clinical response in acute schizophrenia

1 reference

12 December 2020

Thiothixene plasma levels and clinical response in acute schizophrenia.

1 reference

12 December 2020

Haloperidol plasma levels and clinical response in paranoid schizophrenics

1 reference

12 December 2020

Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs

1 reference

12 December 2020

The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol

1 reference

12 December 2020

Serum haloperidol determinations in psychiatric patients. Comparison of methods and correlation with serum prolactin level

1 reference

12 December 2020

Serum level of haloperidol and its clinical significance

1 reference

12 December 2020

Improved liquid-chromatographic determination of haloperidol in plasma

1 reference

12 December 2020

Plasma and red cell levels of thioridazine and clinical response in schizophrenia

1 reference

12 December 2020

Serum level monitoring of thiothixene in schizophrenia: acute single-dose levels at fixed doses

1 reference

12 December 2020

Assay of plasma thioridazine and metabolites by high-performance liquid chromatography with amperometric detection

1 reference

12 December 2020

Pharmacokinetics of methotrimeprazine after single and multiple doses

1 reference

12 December 2020

Effect of anticonvulsants on plasma haloperidol and thioridazine levels

1 reference

12 December 2020

Red blood cell/plasma haloperidol ratios and antipsychotic efficacy

1 reference

12 December 2020

Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients

1 reference

12 December 2020

Determination of chlorprothixene and its sulfoxide metabolite in plasma by high-performance liquid chromatography with ultraviolet and amperometric detection

1 reference

12 December 2020

[Quantitative approach to treatment with incisive neuroleptics by therapeutic monitoring]

1 reference

12 December 2020

Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine

1 reference

12 December 2020

Plasma haloperidol levels and clinical response: confounding variables

1 reference

12 December 2020

Effects of mode of management on plasma chlorpromazine in psychiatric patients.

1 reference

12 December 2020

Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patients

1 reference

12 December 2020

A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency

1 reference

12 December 2020

Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice

1 reference

12 December 2020

Serum effects confound the neuroleptic radioreceptor assay

1 reference

12 December 2020

Gas chromatographic mass spectrometric identification of O-demethylated and mono-hydroxylated metabolites of levomepromazine in blood from psychiatric patients by selected ion recording with high resolution.

1 reference

12 December 2020

Clinical relevance of thiothixene plasma levels

1 reference

12 December 2020

Pharmacokinetic aspects of new antipsychotic drugs

1 reference

12 December 2020

Monitoring of haloperidol serum levels and it's clinical significance.

1 reference

12 December 2020

Subnanogram quantitation of chlorpromazine in plasma by high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations

1 reference

12 December 2020

Plasma levels of chlorpromazine in schizophrenia; a critical review of the literature

1 reference

12 December 2020

A high-performance liquid chromatographic method for the assay of perphenazine and its dealkylated metabolite in serum after therapeutic doses

1 reference

12 December 2020

Haloperidol levels and clinical response

1 reference

12 December 2020

RBC and plasma levels of haloperidol and clinical response in schizophrenia

1 reference

12 December 2020

Serum concentration of depot neuroleptics in tardive dyskinesia

1 reference

12 December 2020

Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia

1 reference

12 December 2020

Neuroleptic blood levels in outpatient maintenance therapy of schizophrenia

1 reference

12 December 2020

Blood levels of haloperidol in schizophrenic patients

1 reference

12 December 2020

Therapeutic drug monitoring of psychotropic drugs in children

1 reference

12 December 2020

Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.

1 reference

12 December 2020

Haloperidol plasma and red blood cell levels and clinical antipsychotic response

1 reference

12 December 2020

Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses

1 reference

12 December 2020

10.2165/00003088-198611010-00003

Identifiers

DOI

1 reference

PubMed ID

2868820

Dimensions Publication ID

11 September 2017

0 references

1 reference

PubMed ID

2868820